跳至主要内容
临床试验/IRCT20180125038507N1
IRCT20180125038507N1已完成3 期

Study of the therapeutic effects of Atomoxetine in comparison with placebo on reducing the incidence of symptoms in patients with recurrent vasovagal syncope;

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
10 years 至 70 years(—)
性别
All

入选标准

  • Patients who come to the Tehran Heart Center with a complaint of syncope or pre-syncope with the clinical diagnosis of vasovagal syncope or have undergone tilt test, if needed, and experienced at least 3 syncopal episodes in the past 3 months.

排除标准

  • Age under 10 or over 70 years old
  • History of uncontrolled blood pressure
  • History of structural heart disease
  • History of epilepsy
  • History of closed angle glaucoma
  • History of diabetes mellitus
  • History of coronary artery disease
  • Ejection fraction < 50%
  • Use of monoamine oxidase inhibitors (MAOIs)
  • Use of selective serotonin reuptake inhibitors (SSRIs)
  • Use of anticonvulsants

研究者

相似试验